Soliton Inc
  • Technology
  • Trials
  • Tattoo Standards
  • About
  • Investors
  • News
  • Sign-Up

In The News

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Scientific Advisory Board
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • In The News
  • IR Calendar

MATV News: Aesthetic Procedures on the Rise; FDA Approvals for Soliton RAP and Pulse Cell FX; ASDS Filler Task Force; Thriving in Aesthetics

Feb 12, 2021

DermWireTV: Pulse's CellFX, Soliton's RAP Technology, Belotero Balance (+), Restylane Defyne, Eczema Costs

Feb 11, 2021

MedEsthetics: Soliton Receives FDA Clearance for Cellulite Improvement

Feb 3, 2021

American Spa: Soliton Announces FDA Clearance Of RAP Technology For Use In Cellulite Treatments

Feb 3, 2021

Modern Aesthetics: Soliton’s RAP Technology Cleared for Cellulite

Feb 3, 2021

Practical Dermatology: Soliton's RAP Technology Now Cleared for Cellulite

Feb 3, 2021

PSP: FDA Clears Rapid Acoustic Pulse Technology by Soliton

Feb 2, 2021

DermatologyTimes: FDA Clears Soliton’s RAP Device for Cellulite

Feb 2, 2021

BioWorld: Regulatory actions for Feb. 1, 2021

Feb 1, 2021

FDA Awards 510(k) Clearance for Rapid Pulse Device to Remove Cellulite

Feb 1, 2021
RSS
  • 1
  • 2
  • 3
  • Next »

To Follow Our Progress, Sign Up Here:

Additional Information

  • Privacy Policy
  • Contact

Social Media

Links

  • About
  • Technology
  • Trials
  • Tattoo Standards

© 2021 Soliton Inc. All Rights Reserved, Soliton Inc.

    • Clinicians
    • Patients
    • RAP
    • Trials
    • Standards
    • Our Future
    • About
    • Investors